RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Something I just seen !cytochrome wrote: Good one! i'm reeling over here lol. I actually posted positive research on the tiopic should you care to read. I thought this board is interested in objective debate and intelligent discourse. I stand corrected based on your comments...thanks for straightening me out ;)
Welcome to the SH board cyto but Id advise quickly figuring out the couple of posters here actually worth reading and ignoring the vast majority of ankle biters who will attack any poster who dares question that their blessed Theralase isnt headed to $20 very soon. Theres virtually no discussion or desire to understand the reality of the current share structure limiting factors, estimated peak sales valuation metrics relative to market cap, peer competitiveness or commercially viability. Just an onslaught of posts regarding how ruvidar is the best and only gold standard of care and the stock is headed to the moon! Ill keep my feet on the ground. Im too long in the tooth to stubbornly wear rose colored glassesAll imo.